Dr Bingyang Shi is Chair Professor of Nanomedicine at UTS and a globally recognized leader in brain-targeted drug delivery. His work integrates nanomedicine, targeted protein degradation and biomolecular engineering to create next-generation therapeutic strategies to address major global health challenges in brain.

He publishes in leading international journals including nature nanotechnology, nature biomedical engineering and Science Translational Medicine leads interdisciplinary NHMRC and ARC research projects and serves as Executive Editor-in-Chief of journal Exploration, a flagship comprehensive journal with Wiley.